Pharmaceuticals in Asia-Pacific - Research and Markets

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The Asia-Pacific pharmaceuticals market registered revenues of $391.3 billion in 2023, representing a compound annual growth rate (CAGR) of 6.5% between 2018 and 2023.
China dominated the Asia-Pacific pharmaceuticals market in 2023, accounting for the largest share of 41.1% in 2023.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Asia-Pacific pharmaceuticals market by value in 2023?
What will be the size of the Asia-Pacific pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Asia-Pacific's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the recent developments in the market?

8 Company Profiles

8.1. CSPC Pharmaceutical Group Ltd
8.2. Takeda Pharmaceutical Co Ltd
8.3. Shanghai Pharmaceuticals Holding Co Ltd
8.4. Sinopharm Group Co Ltd

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23
Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: CSPC Pharmaceutical Group Ltd: Key Facts
Table 5: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 6: CSPC Pharmaceutical Group Ltd: Key Employees
Table 7: Takeda Pharmaceutical Co Ltd: Key Facts
Table 8: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Takeda Pharmaceutical Co Ltd: Key Employees
Table 10: Takeda Pharmaceutical Co Ltd: Key Employees Continued
Table 11: Shanghai Pharmaceuticals Holding Co Ltd: Key Facts
Table 12: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 13: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 14: Sinopharm Group Co Ltd: Key Facts
Table 15: Sinopharm Group Co Ltd: Annual Financial Ratios
Table 16: Sinopharm Group Co Ltd: Key Employees
Table 17: Asia-Pacific Exchange Rate, 2018-23

List of Figures

Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23
Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28
Figure 4: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2023
Figure 5: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2023
Figure 6: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2023
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2023
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2023
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

CSPC Pharmaceutical Group Ltd
Takeda Pharmaceutical Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Sinopharm Group Co Ltd

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€345EUR$350USD£286GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€517EUR$525USD£428GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€689EUR$700USD£571GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceutical Industry Outlook, 2024

Autologous Cell Therapies - Global Strategic Business Report

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028

Pharmaceuticals in China

Pharmaceutical Drugs Global Market Report 2024